BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2843986)

  • 1. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.
    Geller AI; Breakefield XO
    Science; 1988 Sep; 241(4873):1667-9. PubMed ID: 2843986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.
    Geller AI; Freese A
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1149-53. PubMed ID: 2153970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
    Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
    Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac.
    Geller AI
    J Virol Methods; 1991; 31(2-3):229-38. PubMed ID: 1650784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters.
    Geller AI
    J Neurosci Methods; 1991 Jan; 36(1):91-103. PubMed ID: 1648153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.
    Freese A; Geller A
    Nucleic Acids Res; 1991 Dec; 19(25):7219-23. PubMed ID: 1662813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
    Geller AI; Keyomarsi K; Bryan J; Pardee AB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
    Kim T; Leibfried-Rutledge ML; First NL
    Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A herpes simplex virus-1 vector containing the rat tyrosine hydroxylase promoter directs cell type-specific expression of beta-galactosidase in cultured rat peripheral neurons.
    Oh YJ; Moffat M; Wong S; Ullrey D; Geller AI; O'Malley KL
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):227-36. PubMed ID: 8717359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.
    Brubaker JO; Thompson CM; Morrison LA; Knipe DM; Siber GR; Finberg RW
    J Immunol; 1996 Aug; 157(4):1598-604. PubMed ID: 8759744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system.
    Ho DY; McLaughlin JR; Sapolsky RM
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):200-9. PubMed ID: 8883953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector.
    Johnson PA; Yoshida K; Gage FH; Friedmann T
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):95-102. PubMed ID: 1312210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants.
    Chiocca EA; Choi BB; Cai WZ; DeLuca NA; Schaffer PA; DiFiglia M; Breakefield XO; Martuza RL
    New Biol; 1990 Aug; 2(8):739-46. PubMed ID: 2178004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the E. coli Lac Z gene from a defective HSV-1 vector in various human normal, cancer-prone and tumor cells.
    Boothman DA; Geller AI; Pardee AB
    FEBS Lett; 1989 Nov; 258(1):159-62. PubMed ID: 2556295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
    Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
    Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse.
    Ho DY; Mocarski ES
    Virology; 1988 Nov; 167(1):279-83. PubMed ID: 2847416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpesviruses: expression of genes in postmitotic brain cells.
    Geller AI
    Curr Opin Genet Dev; 1993 Feb; 3(1):81-5. PubMed ID: 8384036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector.
    Smith RL; Geller AI; Escudero KW; Wilcox CL
    J Virol; 1995 Aug; 69(8):4593-9. PubMed ID: 7609023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
    Huard J; Goins WF; Glorioso JC
    Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
    Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM
    Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.